Cargando…
Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1
Next generation sequencing studies in chronic lymphocytic leukemia (CLL) have revealed novel genetic variants that have been associated with disease characteristics and outcome. The aim of this study was to evaluate the prognostic value of recurrent molecular abnormalities in patients with CLL. Ther...
Autores principales: | Tausch, Eugen, Beck, Philipp, Schlenk, Richard F., Jebaraj, Billy M.C., Dolnik, Anna, Yosifov, Deyan Y., Hillmen, Peter, Offner, Fritz, Janssens, Ann, Babu, K. Govind, Grosicki, Sebastian, Mayer, Jiri, Panagiotidis, Panagiotis, McKeown, Astrid, Gupta, Ira V., Skorupa, Alexandra, Pallaud, Celine, Bullinger, Lars, Mertens, Daniel, Döhner, Hartmut, Stilgenbauer, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556677/ https://www.ncbi.nlm.nih.gov/pubmed/33054084 http://dx.doi.org/10.3324/haematol.2019.229161 |
Ejemplares similares
-
DNA methylation of chronic lymphocytic leukemia with differential response to chemotherapy
por: Yosifov, Deyan Yordanov, et al.
Publicado: (2020) -
Acquired BTK mutations associated with resistance to noncovalent BTK inhibitors
por: Qi, Jialei, et al.
Publicado: (2023) -
P614: NOVEL SPLICE-SITE MUTATION IN PLCG2 ASSOCIATED WITH RESISTANCE TO BTK INHIBITORS
por: Qi, Jialei, et al.
Publicado: (2023) -
Clonal evolution in chronic lymphocytic leukemia is scant in relapsed but accelerated in refractory cases after chemo(immune) therapy
por: Zapatka, Marc, et al.
Publicado: (2021) -
From Biology to Therapy: The CLL Success Story
por: Yosifov, Deyan Y., et al.
Publicado: (2019)